For patients with both obesity and type 2 diabetes indications recorded, we included them in both the obesity and type 2 diabetes subgroup analyses to capture the full scope of potential risk
At mid-range doses like 75 units, most patients experience manageable nausea, reduced appetite, and occasional digestive changes that typically improve within one to two weeks
GLP-1 10mg Summary Description: Semaglutide is a synthetic, long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA) used primarily for the treatment of type 2 diabetes and, at higher doses, for chronic weight management in adults with overweight or obesity
Prioritize protein and complex carbohydrates
Physician-guided GLP-1 treatment everything included in your care Your personalized GLP-1 plan Your longevity journey begins with membership Your Direct Preventive Care team reviews your health history, goals, and baseline labs to confirm eligibility and design a protocol personalized to you